Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making

Journal of Clinical Oncology

Volumn 23, Issue 30, 2005, Pages 7594-7603

  Malcovati, Luca ^a   Della Porta, Matteo Giovanni ^a   Pascutto, Cristiana ^a   Invernizzi, Rosangela ^a   Boni, Marina ^a   Travaglino, Erica ^a   Passamonti, Francesco ^a   Arcaini, Luca ^a   Maffioli, Margherita ^a   Bernasconi, Paolo ^a   Lazzarino, Mario ^a   Cazzola, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IRON OVERLOAD; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA AND RINGED SIDEROBLASTS; RETROSPECTIVE STUDY; STANDARDIZATION; TRANSFUSION; WORLD HEALTH ORGANIZATION; BLOOD TRANSFUSION; BONE MARROW; CLASSIFICATION; COMPARATIVE STUDY; DECISION MAKING; DEMOGRAPHY; GENETICS; KARYOTYPING; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; BONE MARROW; DECISION MAKING; DEMOGRAPHY; FEMALE; HUMANS; KARYOTYPING; LIFE EXPECTANCY; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 32144431895     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.7038     Document Type: Article

References (28)

1. Cazzola M, Malcovati L: Myelodysplastic syndromes: Coping with ineffective hematopoiesis. N Engl J Med 352:536-538, 2005
2. Bennett JM, Catovsky D, Daniel MT, et al: Proposals for the classification of the myelodys-plastic syndromes. Br J Haematol 51:189-199, 1982
3. Sanz GF, Sanz MA, Greenberg PL: Prognostic factors and scoring systems in myelodysplastic syndromes. Haematologica 83:358-368, 1998
4. Verhoef GE, Pittaluga S, De Wolf-Peeters C, et al: FAB classification of myelodysplastic syndromes: Merits and controversies. Ann Hematol 71:3-11, 1995
5. Rosati S, Mick R, Xu F, et al: Refractory cytopenia with multilineage dysplasia: Further characterization of an 'unclassifiable' myelodysplastic syndrome. Leukemia 10:20-26, 1996
6. Boultwood J, Lewis S, Wainscoat JS: The 5q-syndrome. Blood 84:3253-3260, 1994
7. Morel P, Hebbar M, Lai JL, et al: Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report on 408 cases. Leukemia 7:1315-1323, 1993
8. Sanz GF, Sanz MA, Vallespi T, et al: Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: A multivariate analysis of prognostic factors in 370 patients. Blood 74:395-408, 1989
9. Mufti GJ, Stevens JR, Oscier DG, et al: Myelodysplastic syndromes: A scoring system with prognostic significance. Br J Haematol 59: 425-433, 1985
10. Aul C, Gattermann N, Heyll A, et al: Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6:52-59, 1992
11. Greenberg P, Cox C, LeBeau MM, et al: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89: 2079-2088, 1997
12. Estey E, Keating M, Pierce S, et al: Application of the International Scoring System for myelodysplasia to M.D. Anderson patients. Blood 90:2843-2846, 1997
13. Pfeilstocker M, Reisner R, Nosslinger T, et al: Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics. Br J Haematol 106:455-463, 1999
14. Takahashi M, Takahashi H, Aizawa Y, et al: Usefulness of IPSS for the patients with refractory anemia. Am J Hematol 58:250-252, 1998
15. Vardiman JW, Harris NL, Brunning RD: The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100:2292-2302, 2002
16. Germing U, Gattermann N, Strupp C, et al: Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: A retrospective analysis of 1600 patients. Leuk Res 24:983-992, 2000
17. Nosslinger T, Reisner R, Koller E, et al: Myelodysplastic syndromes, from French-American-British to World Health Organization: Comparison of classifications on 431 unselected patients from a single institution. Blood 98:2935-2941, 2001
18. Howe RB, Porwit-MacDonald A, Wanat R, et al: The WHO classification of MDS does make a difference. Blood 103:3265-3270, 2004
19. Verburgh ER, Achten R, Brusselmans C, et al: A new disease definition of low grade MDS based on the expression of cytopenia and dysplasia in one or more lineages at diagnosis improves on the FAB and WHO classification. Hematol J 5:S90-S91, 2004 (suppl 2)
20. Bernasconi P, Astori C, Cavigliano PM, et al: Cytogenetic and FISH analyses in five patients with hypoplastic bone marrow. Leukemia 14: 1322-1323, 2000
21. An International System for Human Cytogenetic Nomenclature: (1985) ISCN 1985-Report of the Standing Committee on Human Cytogenetic Nomenclature. Birth Defects Orig Artic Ser 21:1-117, 1985
22. Bowen D, Culligan D, Jowitt S, et al: Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol 120: 187-200, 2003
23. Morel P, Declercq C, Hebbar M, et al: Prognostic factors in myelodysplastic syndromes: Critical analysis of the impact of age and gender and failure to identify a very-low-risk group using standard mortality ratio techniques. Br J Haematol 94:116-119, 1996
24. Anderson JE, Appelbaum FR, Fisher LD, et al: Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 82:677-681, 1993
25. de Witte T, Hermans J, Vossen J, et al: Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 110:620630, 2000
26. Sierra J, Perez WS, Rozman C, et al: Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood 100:1997-2004, 2002
27. Alessandrino EP, Amadori S, Barosi G, et al: Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes: A statement from the Italian Society of Hematology. Haematologica 87:1286-1306, 2002
28. Cutler CS, Lee SJ, Greenberg P, et al: A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: Delayed transplantation for low risk myelodysplasia is associated with improved outcome. Blood 104: 579-585, 2004